Understanding Atomoxetine Exposure Variability in Children and Adolescents With ADHD Through Population Pharmacokinetics

Ähnliche Einträge

• Response to Letter to the Editor from Madhuri Tribhuvan and Shashikant N. Phatke
  von: Kevin. V. Tobin, et al.
  Veröffentlicht: (2026)
• Comment on “Understanding Atomoxetine Exposure Variability in Children and Adolescents with ADHD through Population Pharmacokinetics”
  von: Madhuri Tribhuvan, et al.
  Veröffentlicht: (2026)
• Population Pharmacokinetic Analysis of Atomoxetine and its Metabolites in Children and Adolescents with Attention‐Deficit /Hyperactivity Disorder
  von: Shen Cheng, et al.
  Veröffentlicht: (2024)
• Guiding Dyslipidemia Treatment: A Population Pharmacokinetic–Pharmacodynamic Framework for Obicetrapib
  von: Allison Dunn, et al.
  Veröffentlicht: (2024)
• Correction to “Population Pharmacokinetic Analysis of Atomoxetine and its Metabolites in Children and Adolescents with Attention‐Deficit/Hyperactivity Disorder”
  Veröffentlicht: (2025)